Incannex Healthcare (IXHL) Interest Coverage Ratio (2024 - 2025)

Incannex Healthcare's (IXHL) quarterly Interest Coverage Ratio came in at 1399.0 in Q4 2025, up 682.81% year-on-year from 178.71 in Q4 2024, and up 2.96% quarter-over-quarter from 1358.8 in Q3 2025.

Incannex Healthcare (IXHL) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

Incannex Healthcare has disclosed Interest Coverage Ratio across 2 years of filings, most recently posting 1399.0 for Q4 2025.

  • Interest Coverage Ratio for Q4 2025 came in at 1399.0, up 682.81% year-over-year; the trailing twelve-month figure through Mar 2026 was 2536.5 (up 841.3% YoY), and the FY2025 annual result was 78.51, changed N/A from the prior year.
  • Interest Coverage Ratio came in at 1399.0 for Q4 2025 at Incannex Healthcare, up from 1358.8 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1399.0 in Q4 2025 to a low of 37.9 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 13.44
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 108.60
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 5.39
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.31
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 16.72
10 Incannex Healthcare 45.81 Mn 45.81 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,399.00
Sep 30, 2025 1,358.80
Mar 31, 2025 -37.90
Dec 31, 2024 178.71
Sep 30, 2024 223.36